Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement Claim Review Program Sees Cooperation, NAD Says

This article was originally published in The Tan Sheet

Executive Summary

The National Advertising Division says its targeted review of dietary supplement advertising claims is increasing compliance, with most firms cooperating

You may also be interested in...



Perrigo Verdict Could Bolster Store Brand Equivalency Claims

A federal court jury ruled Perrigo did not falsely advertise when it claimed its private label glucosamine and chondroitin supplements are comparable to Rexall Sundown's Osteo Bi-Flex joint care products

Perrigo Verdict Could Bolster Store Brand Equivalency Claims

A federal court jury ruled Perrigo did not falsely advertise when it claimed its private label glucosamine and chondroitin supplements are comparable to Rexall Sundown's Osteo Bi-Flex joint care products

Perrigo Verdict Could Bolster Store Brand Equivalency Claims

A federal court jury ruled Perrigo did not falsely advertise when it claimed its private label glucosamine and chondroitin supplements are comparable to Rexall Sundown's Osteo Bi-Flex joint care products

Related Content

Topics

UsernamePublicRestriction

Register

PS103444

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel